EMBARK VETERINARY INC, a canine genomics company that offers dog DNA testing services to pet owners, breeders, and veterinarians, recently ANNOUNCED a $75 Million Series B funding round by SoftBank Vision Fund 2.
The $75 Million investment will be used to make key hires and to strengthen it’s canine genetics database.
Embark’s Dog DNA Kit can test and determine over 350 breeds, and more than 200 genetic health risks, by employing proprietary genotyping technology that analyzes 200,000 genetic markers, according to the company.
By the end of 2021 Embark expects to process nearly 1 million tests creating the world’s largest database of canine health and biological information.
PRESS RELEASE: Embark Veterinary Announces $75M Series B Funding Led by SoftBank Vision Fund 2 (7.26.21)
- CRUNCHBASE: Company Profile and Funding for Embark Veterinary
– The new funding round increases Embark’s total funding amount to $94.3 million since the company was founded in 2015.